clinical trials

Nanoscope Therapeutics Bolsters Board with Addition of Ophthalmic Veteran as Strategic Adviser

by | Mar 22, 2023
Nanoscope Therapeutics has enlisted the expertise of Vicente Anido Jr., Ph.D. to help the company advance its goal of developing sight-restoring gene therapies for retinal degenerative diseases. Anido's appointment as a strategic adviser is expected to support Nanoscope's clinical and corporate strategies, especially as the company progresses towards the potential commercialization of MCO-010.
MORE
5 Ways UT Southwestern Medical Center Is Fighting COVID
by | Aug 4, 2020
Virus researchers at UT Southwestern Medical Center have amped up their lab and data work to fight and defeat COVID-19. Here are key takeaways from UTSW's Claire Aldridge, who herself has battled the virus and fully recovered.
MORE
Dallas’ Peloton Therapeutics Exits to Merck in $2.2B Deal
by | May 22, 2019
The clinical-stage oncology company develops small molecule drugs to treat kidney cancer and other diseases. Its renal cell carcinoma drug is in a Phase II clinical trial.
MORE
eye

R&D: UNTHSC Finds Hope for Sight-Stealing Eye Disease, UTA Engineers Stronger Walls with Recycled Plastic

by | Oct 12, 2018
Also, you'll learn how Galderma has boosted its R&D investment and boosted its clinical trials. Here are some of the research projects underway in North Texas that could make lives better.
MORE
thinking
Discovery: Innovative Thinking Study, Cancer Survivors & Clinical Trials, Quake Sensors
by | Dec 1, 2017
Researchers are making discoveries and breakthroughs at laboratories and institutions all across North Texas. Here are some of their stories.
MORE